Firm to seek USDA approval for peanut-allergy product
To those allergic to peanut, there’s now hope for you to have your peanut butter jelly time!
Kids allergic to peanuts may soon enjoy the food without worrying over its effects on their body as a treatment may soon find its way in the market.
California-based Aimmune Therapeutics said its daily capsules of peanut powder helped kids build tolerance in a major study. About 67 percent of children who participated in the experiment were able to take in a total of roughly two peanuts without any allergic reaction by the end of the study.
Meanwhile, a fifth of the kids getting the peanut powder dropped out of the test. About 12 percent of them cited reactions or other issues. Dr. Stacie Jones, a University of Arkansas allergy specialist who lead the study said the product showed “overall good safety” quality.
The results of the study is slated to be out next month and Aimmune will seek for approval from the U.S. Food and Drug Administration later this year and from European regulators early next year.
The first six months of treatment is estimated to cost $5,000 to $10,000. Treatment after that period may range from $300 to $400 a month.